Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data-Reference-Cited by-同舟云学术

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Published:2012-01-30 Issue:3 Volume:39 Page:564-574
ISSN:1745-1701
Container-title:Schizophrenia Bulletin
language:en
Short-container-title:

Author:

Sakurai Hitoshi,Bies Robert R.,Stroup Scott T.,Keefe Richard S. E.,Rajji Tarek K.,Suzuki Takefumi,Mamo David C.,Pollock Bruce G.,Watanabe Koichiro,Mimura Masaru,Uchida Hiroyuki

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health

Link

http://academic.oup.com/schizophreniabulletin/article-pdf/39/3/564/16975341/sbr189.pdf

Reference53 articles.

1. What are the functional consequences of neurocognitive deficits in schizophrenia?;Green;Am J Psychiatry,1996

2. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder;Elie;J Psychopharmacol,2010

3. Processing speed deficits in schizophrenia: reexamining the evidence;Knowles;Am J Psychiatry,2010

4. Antipsychotic medication and cognitive function in schizophrenia;Hori;Schizophr Res,2006

5. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis;Keefe;Schizophr Bull,1999

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia;Psychiatry Research;2024-10

2. Diverging functional connectivity timescales: Capturing distinct aspects of cognitive performance in early psychosis;2024-05-08

3. Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments;Pharmacopsychiatry;2024-05-06

4. The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review;Brain Sciences;2024-04-03

5. A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature;Journal of Psychopharmacology;2024-03-17